Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19
Journal of Clinical Medicine · 20.06.2023 · 12 (12) · 4158
DOI: 10.3390/jcm12124158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.06.2023. Verfasst von Diana Badenes Bonet und 19 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Medicine Department, Hospital del Mar, 08003 Barcelona, Spain. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The post-acute sequelae of SARS-CoV-2 (PASC) infection have caused a significant impact on our health system, but there is limited evidence of approved drugs focused on its prevention. Our objective was to identify risk factors that can determine the presence of PASC, with special attention to the treatment received in the acute phase, and to describe the profile of persistent symptoms in a multidisciplinary Post-Coronavirus Disease-19 (COVID-19) Unit.
Methods
This one-year prospective observational study included patients following an acute COVID-19 infection, irrespective of whether they required hospital admission. A standardized symptom questionnaire and blood sampling were performed at the first follow-up visit, and demographic and clinical electronic data were collected. We compared subjects with PASC with those who had fully recovered. Multivariate logistic regression was performed to identify factors associated with PASC in hospitalized patients, and Kaplan–Meier curves were used to assess duration of symptoms according to disease severity and treatments received in the acute phase.
Results
1966 patients were evaluated; 1081 had mild disease, 542 moderate and 343 severe; around one third of the subjects had PASC, and were more frequently female, with obesity, asthma, and eosinophilia during acute COVID-19 disease. Patients who received treatment with dexamethasone and remdesivir during the course of the acute illness showed a lower median duration of symptoms, compared with those who received none of these treatments.
Conclusion
Treatment with dexamethasone and/or remdesivir may be useful to reduce the impact of PASC secondary to SARS-CoV-2 infection. In addition, we identified female gender, obesity, asthma, and disease severity as risk factors for having PASC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Respiratory Medicine Department, Hospital del Mar, 08003 Barcelona, Spain.
- Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.
- Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
- Assessoria Metodològica i Bioestadística (AMIB), 08003 Barcelona, Spain.
- Epidemiology and Evaluation Department, Hospital del Mar, REDISSEC, RICAPPS, 08003 Barcelona, Spain.
- Neurology Department, Hospital del Mar, 08003 Barcelona, Spain.
ORCID-Profile: Oswaldo Antonio Caguana Vélez, Merce Comas Serrano, Elisa Cuadrado Godia, Ester Marco Navarro, Gemma Martin Ezquerra, Maria Cinta Cumpli Gargallo, Jose Gregorio Gonzalez Garcia, Diego Rodriguez Chiaradia, Juan P Horcajada
Zitieren
APA
Badenes Bonet, D., Caguana Vélez, O. A., Duran Jordà, X., Comas Serrano, M., Posso Rivera, M., Admetlló, M., Herranz Blasco, A., Cuadrado Godia, E., Marco Navarro, E., Martin Ezquerra, G., Pineiro Aguin, Z., Cumpli Gargallo, M. C., Gonzalez Garcia, J. G., Balcells Vilarnau, E., Rodriguez Chiaradia, D., Castells, X., Gea, J., Horcajada, J. P., Villar-García, J., & MAR Post-COVID-19 Unit (2023). Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19. Journal of Clinical Medicine, 12(12), 4158. https://doi.org/10.3390/jcm12124158
Vancouver
Badenes Bonet D, Caguana Vélez OA, Duran Jordà X, Comas Serrano M, Posso Rivera M, Admetlló M, et al. Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19. Journal of Clinical Medicine. 2023;12(12):4158. doi:10.3390/jcm12124158
BibTeX
@article{BadenesBonet2023,
author = {Badenes Bonet, Diana and Caguana Vélez, Oswaldo Antonio and Duran Jordà, Xavier and Comas Serrano, Merce and Posso Rivera, Margarita and Admetlló, Mireia and Herranz Blasco, Anna and Cuadrado Godia, Elisa and Marco Navarro, Ester and Martin Ezquerra, Gemma and Pineiro Aguin, Zenaida and Cumpli Gargallo, Maria Cinta and Gonzalez Garcia, Jose Gregorio and Balcells Vilarnau, Eva and Rodriguez Chiaradia, Diego and Castells, Xavier and Gea, Joaquim and Horcajada, Juan P and Villar-García, Judit and MAR Post-COVID-19 Unit, MAR Post-COVID-19 Unit},
title = {Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {12},
pages = {4158},
doi = {10.3390/jcm12124158}
}
EUVIMED